Envision Healthcare (EVHC) Receives $40.19 Consensus PT from Brokerages

Share on StockTwits

Shares of Envision Healthcare (NYSE:EVHC) have been given an average recommendation of “Hold” by the nineteen brokerages that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $40.19.

EVHC has been the topic of several recent analyst reports. Jefferies Financial Group set a $46.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Thursday, March 15th. Raymond James reiterated a “market perform” rating and issued a $51.00 target price on shares of Envision Healthcare in a research note on Tuesday, June 12th. Robert W. Baird set a $45.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Monday, February 26th. William Blair cut shares of Envision Healthcare from an “outperform” rating to a “market perform” rating in a research note on Monday, June 11th. Finally, ValuEngine cut shares of Envision Healthcare from a “sell” rating to a “strong sell” rating in a research note on Wednesday, May 2nd.

Envision Healthcare traded down $0.07, hitting $44.68, on Monday, according to MarketBeat Ratings. The stock had a trading volume of 8,161,292 shares, compared to its average volume of 7,490,349. Envision Healthcare has a 52-week low of $23.77 and a 52-week high of $64.00. The company has a debt-to-equity ratio of 0.65, a current ratio of 2.27 and a quick ratio of 2.25. The stock has a market capitalization of $5.42 billion, a PE ratio of 18.02, a P/E/G ratio of 1.10 and a beta of 0.46.

Envision Healthcare (NYSE:EVHC) last posted its earnings results on Monday, May 7th. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.07. Envision Healthcare had a net margin of 1.41% and a return on equity of 4.59%. The business had revenue of $2.08 billion for the quarter, compared to analysts’ expectations of $2.02 billion. During the same period in the prior year, the company posted $0.77 EPS. The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. research analysts anticipate that Envision Healthcare will post 3.41 EPS for the current year.

Several institutional investors have recently bought and sold shares of the company. Federated Investors Inc. PA raised its position in Envision Healthcare by 194.8% in the 1st quarter. Federated Investors Inc. PA now owns 2,753 shares of the company’s stock worth $106,000 after purchasing an additional 1,819 shares during the period. Rampart Investment Management Company LLC raised its position in Envision Healthcare by 124.4% in the 1st quarter. Rampart Investment Management Company LLC now owns 3,362 shares of the company’s stock worth $129,000 after purchasing an additional 1,864 shares during the period. OLD Mutual Customised Solutions Proprietary Ltd. raised its position in Envision Healthcare by 88.2% in the 4th quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company’s stock worth $221,000 after purchasing an additional 3,000 shares during the period. Verition Fund Management LLC purchased a new position in Envision Healthcare in the 1st quarter worth $221,000. Finally, Element Capital Management LLC purchased a new position in Envision Healthcare in the 1st quarter worth $227,000.

Envision Healthcare Company Profile

Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Analysts Anticipate Trade Desk Inc  Will Post Quarterly Sales of $103.67 Million
Analysts Anticipate Trade Desk Inc Will Post Quarterly Sales of $103.67 Million
Gap Inc  Expected to Announce Quarterly Sales of $3.98 Billion
Gap Inc Expected to Announce Quarterly Sales of $3.98 Billion
Sinovac Biotech  Given Daily Media Impact Rating of -0.02
Sinovac Biotech Given Daily Media Impact Rating of -0.02
Limoneira  Receives Daily News Sentiment Rating of 0.06
Limoneira Receives Daily News Sentiment Rating of 0.06
Motorola Solutions  Hits New 1-Year High at $121.69
Motorola Solutions Hits New 1-Year High at $121.69
Vince  Hits New 52-Week High at $20.35
Vince Hits New 52-Week High at $20.35


© 2006-2018 Ticker Report. Google+.